LumiraDx Limited (LMDX) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Diagnostics & Research 行业. 公司总部位于 London, 英国. 现任CEO为 Veronique Ameye EMBA,.
LMDX 拥有 IPO日期为 2021-03-19, 1,210 名全职员工, 在 NASDAQ Global Market, 市值为 $5.1M.
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.
